Our study also found that 12 (9.8%) BBC patients carried BRCA2 deleterious variants, higher than eight (6.5%) identified with BRCA1 deleterious variants, which was similar to other Chinese studies that evaluated unselected breast cancer patients [27, 28, 31]. This evidence concerns the gene BRCA2 and breast cancer.